BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38062922)

  • 1. Tryptophan metabolism enzymes are potential targets in ovarian clear cell carcinoma.
    Zhang S; Gao Y; Wang P; Wang S; Wang Y; Li M; Wang A; Zhao K; Zhang Z; Sun J; Guo D; Liang Z
    Cancer Med; 2023 Dec; 12(24):21996-22005. PubMed ID: 38062922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Tryptophan Metabolism Enzymes in Patients with Diffuse Large B-cell Lymphoma and NK/T-cell Lymphoma.
    Guo D; Wang Y; Wu X; Gao Y; Wang A; Zhang Z; Zhao K; Wang X; Liu M; Zhang Y; Li M; Chen R; Sun J; Zhang Y
    Cancer Med; 2023 Jun; 12(11):12139-12148. PubMed ID: 37148546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 Expression.
    Crump LS; Floyd JL; Kuo LW; Post MD; Bickerdike M; O'Neill K; Sompel K; Jordan KR; Corr BR; Marjon N; Woodruff ER; Richer JK; Bitler BG
    Cancer Res Commun; 2024 Mar; 4(3):822-833. PubMed ID: 38451784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice.
    Aslamkhan AG; Xu Q; Loughlin A; Vu H; Pacchione S; Bhatt B; Garfinkel I; Styring TG; LaFranco-Scheuch L; Pearson K; Reynolds S; Li N; Zhou H; Miller JR; Solban N; Bass A; Glaab WE
    Toxicol Appl Pharmacol; 2020 Nov; 406():115216. PubMed ID: 32871117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function.
    Too LK; Li KM; Suarna C; Maghzal GJ; Stocker R; McGregor IS; Hunt NH
    Behav Brain Res; 2016 Oct; 312():102-17. PubMed ID: 27316339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL4i1 and IDO1: Oxidases that control a tryptophan metabolic nexus in cancer.
    Zeitler L; Murray PJ
    J Biol Chem; 2023 Jun; 299(6):104827. PubMed ID: 37196768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.
    Wardhani LO; Matsushita M; Iwasaki T; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
    Hum Pathol; 2019 Feb; 84():52-61. PubMed ID: 30240768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory Factors Galectin-9 and Interferon-Gamma Synergize to Induce Expression of Rate-Limiting Enzymes of the
    Brooks AK; Lawson MA; Rytych JL; Yu KC; Janda TM; Steelman AJ; McCusker RH
    Front Immunol; 2016; 7():422. PubMed ID: 27799931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino Acid-Metabolizing Enzymes in Advanced High-Grade Serous Ovarian Cancer Patients: Value of Ascites as Biomarker Source and Role for IL4I1 and IDO1.
    Grobben Y; den Ouden JE; Aguado C; van Altena AM; Kraneveld AD; Zaman GJR
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765849
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Liu Q; Zhai J; Kong X; Wang X; Wang Z; Fang Y; Wang J
    Mol Ther Oncolytics; 2020 Jun; 17():153-168. PubMed ID: 32346606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.
    Sadik A; Somarribas Patterson LF; Öztürk S; Mohapatra SR; Panitz V; Secker PF; Pfänder P; Loth S; Salem H; Prentzell MT; Berdel B; Iskar M; Faessler E; Reuter F; Kirst I; Kalter V; Foerster KI; Jäger E; Guevara CR; Sobeh M; Hielscher T; Poschet G; Reinhardt A; Hassel JC; Zapatka M; Hahn U; von Deimling A; Hopf C; Schlichting R; Escher BI; Burhenne J; Haefeli WE; Ishaque N; Böhme A; Schäuble S; Thedieck K; Trump S; Seiffert M; Opitz CA
    Cell; 2020 Sep; 182(5):1252-1270.e34. PubMed ID: 32818467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
    Sari S; Tomek P; Leung E; Reynisson J
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of L- and D-5-[
    Tang T; Gill HS; Ogasawara A; Tinianow JN; Vanderbilt AN; Williams SP; Hatzivassiliou G; White S; Sandoval W; DeMent K; Wong M; Marik J
    Nucl Med Biol; 2017 Aug; 51():10-17. PubMed ID: 28511073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian clear cell carcinoma with or without endometriosis origin in a single institution cohort.
    Sun M; Jiang W
    Discov Oncol; 2023 Apr; 14(1):39. PubMed ID: 37004660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptophan catabolism is dysregulated in leiomyomas.
    Chuang TD; Quintanilla D; Boos D; Khorram O
    Fertil Steril; 2021 Oct; 116(4):1160-1171. PubMed ID: 34116832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer.
    Wu C; Spector SA; Theodoropoulos G; Nguyen DJM; Kim EY; Garcia A; Savaraj N; Lim DC; Paul A; Feun LG; Bickerdike M; Wangpaichitr M
    Cancer Metab; 2023 May; 11(1):7. PubMed ID: 37226257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2.
    Tijono SM; Palmer BD; Tomek P; Flanagan JU; Henare K; Gamage S; Braun L; Ching LM
    Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low efficiency IDO2 enzymes are conserved in lower vertebrates, whereas higher efficiency IDO1 enzymes are dispensable.
    Yuasa HJ; Mizuno K; Ball HJ
    FEBS J; 2015 Jul; 282(14):2735-45. PubMed ID: 25950090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials.
    Yuasa HJ; Ball HJ; Ho YF; Austin CJ; Whittington CM; Belov K; Maghzal GJ; Jermiin LS; Hunt NH
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):137-44. PubMed ID: 19402226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.